DavidM.GershensonMD

PubMed

• Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.
  Lilian T Gien, Danielle M Enserro, Linda R Duska, Andrea E Wahner-Hendrickson, Premal H Thaker, Allan Covens, Kathleen N Moore, Robert L Coleman, Matthew S Block, Stev...> ;Gynecologic Oncology. 2024 Apr 10
• The prognostic value of MEK pathway-associated estrogen receptor signaling activity for female cancers.
  Chun Wai Ng, Yvonne T M Tsang, Kwong-Kwok Wong, David M Gershenson> ;British Journal of Cancer. 2024 Apr 6
• High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.
  Robert L Hollis, Richard Elliott, John C Dawson, Narthana Ilenkovan, Rosie M Matthews, Lorna J Stillie, Ailsa J Oswald, Hannah Kim, Marta Llaurado Fernandez, Michael C...> ;Gynecologic Oncology. 2024 Apr 5
• Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
  Legarreta, A., Fellman, B., Foster, K., Vuttaradhi, V., Brodsky, A., Hillman, R., How, J., Handley, K., Glassman, D., Lawson, B., Westin, S., Ramondetta, L., Gershenso...> ;American Journal of Obstetrics and Gynecology. 2024 Jan 6
• 1 citations
  Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.
  Emily M Hinchcliff, Anne Knisely, Naomi Adjei, Bryan Fellman, Ying Yuan, Ami Patel, Cai Xu, Shannon N Westin, Anil K Sood, Pamela T Soliman, Aaron Shafer, Nicole D Fle...> ;Cancer. 2024 Apr 1
• Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.
  Dimitrios Nasioudis, Xiaolei Wang, Gurdial Dhillon, Nawar Latif, Emily M Ko, Robert L Giuntoli 2nd, David Gershenson, Amanda Fader, Mark Carey, Fiona Simpkins> ;International Journal of Gynecological Cancer. 2023 Dec 4
• 2 citations
  Low-grade serous ovarian cancer: expert consensus report on the state of the science.
  Rachel N Grisham, Brian M Slomovitz, Nicole Andrews, Susana Banerjee, Jubilee Brown, Mark S Carey, Herman Chui, Robert L Coleman, Amanda N Fader, Stephanie Gaillard, C...> ;International Journal of Gynecological Cancer. 2023 Sep 4
• 1 citations
  Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas.
  Koji Matsuo, Shinya Matsuzaki, Michihide Maeda, Alesandra R Rau, Kosuke Yoshihara, Ryo Tamura, Muneaki Shimada, Hiroko Machida, Mikio Mikami, Maximilian Klar, Lynda D ...> ;JAMA Network Open. 2023 Jun 1
• Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
  Aaron M Praiss, Austin Miller, Judith Smith, Stuart M Lichtman, Michael Bookman, Carol Aghajanian, Paul Sabbatini, Floor Backes, David E Cohn, Peter Argenta, Michael F...> ;Gynecologic Oncology. 2023 Jul 1
• The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5)...
  Tiffany Y Sia, William P Tew, Christopher Purdy, Dennis S Chi, Andrew W Menzin, John L Lovecchio, Michael A Bookman, David E Cohn, Deanna G Teoh, Michael Friedlander, ...> ;Gynecologic Oncology. 2023 Jun 1
• 1 citations
  Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors.
  Eleonora Khlebus, Veena K Vuttaradhi, Thomas Welte, Namrata Khurana, Joseph Celestino, Hannah C Beird, Curtis Gumbs, Latasha Little, Alejandra Flores Legarreta, Bryan ...> ;Molecular Cancer Research. 2023 May 1
• 1 citations
  Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
  Katherine I Foster, Alejandra Flores Legarreta, Rhea Kamat, Katelyn F Handley, Deanna Glassman, Jeffrey A How, Barrett C Lawson, Shannon N Westin, Lois M Ramondetta, M...> ;American Journal of Obstetrics and Gynecology. 2023 Jun 1
• 4 citations
  Novel therapeutics in low-grade serous ovarian cancer.
  Lauren Cobb, David Gershenson> ;International Journal of Gynecological Cancer. 2023 Mar 6
• 2 citations
  Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.
  Kwong-Kwok Wong, Nicholas W Bateman, Chun Wai Ng, Yvonne T M Tsang, Charlotte S Sun, Joseph Celestino, Tri V Nguyen, Anais Malpica, R Tyler Hillman, Jianhua Zhang, P A...> ;Journal of Translational Medicine. 2022 Dec 17
• 3 citations
  Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expans...
  Shannon N Westin, Siqing Fu, Apostolia Tsimberidou, Sarina Piha-Paul, Fechukwu Akhmedzhanov, Bulent Yilmaz, Lacey McQuinn, Amanda L Brink, Jing Gong, Cheuk Hong Leung,...> ;Gynecologic Oncology. 2023 Jan 1
• 4 citations
  A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial.
  John H Farley, William E Brady, David O'Malley, Keiichi Fujiwara, Kan Yonemori, Albert Bonebrake, Angeles Alvarez Secord, Jean-Marie Stephan, Joan L Walker, Joo-Hyun N...> ;Gynecologic Oncology. 2022 Dec 1
• 3 citations
  Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival.
  David M Gershenson, Lauren P Cobb, Shannon N Westin, Yingao Zhang, Amir Jazaeri, Anais Malpica, Charlotte C Sun> ;Gynecologic Oncology. 2022 Nov 1
• 21 citations
  The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.
  David M Gershenson, Charlotte C Sun, Shannon N Westin, Mostafa Eyada, Lauren P Cobb, Lisa C Nathan, Anil K Sood, Anais Malpica, Robert T Hillman, Kwong K Wong> ;Gynecologic Oncology. 2022 Jun 1
• 64 citations
  Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, ph...
  David M Gershenson, Austin Miller, William E Brady, James Paul, Karen Carty, William Rodgers, David Millan, Robert L Coleman, Kathleen N Moore, Susana Banerjee, Kate C...> ;Lancet. 2022 Feb 5
• 2 citations
  Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
  Premal H. Thaker, Liz Y. Han, Aparna A. Kamat, Jesusa M.G. Arevalo, Rie Takahashi, Chunhua Lu, Nicholas B. Jennings, Guillermo N. Armaiz-Pena, James A. Bankson, Murali...> ;Nature Medicine. 2021 Nov 19
• 3 citations
  Prevalence of predictive biomarkers in a large cohort of molecularly defined adult-type ovarian granulosa cell tumors
  R. Tyler Hillman, Douglas I. Lin, Barrett C Lawson, David M. Gershenson> ;Gynecologic Oncology. 2021 Sep 1
• Editor's Note: The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer.
  Aparna A. Kamat, Mavis S. Fletcher, Lynn M. Gruman, Peter R. Mueller, Adriana Lopez, Charles N. Landen, Liz Y. Han, David M. Gershenson, Anil K. Sood> ;Clinical Cancer Research. 2021 Aug 1
• 4 citations
  Fertility preservation in rare ovarian tumors.
  Anca Chelariu-Raicu, Lauren P. Cobb, David M. Gershenson> ;International Journal of Gynecological Cancer. 2021 Mar 1
• 304 citations
  Ovarian cancer, version 2.2020
  Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Andrew Berchuck, Lee-may Chen, Mihaela C. Cristea, Maria DeRosa, Eric L...> ;Journal of the National Comprehensive Cancer Network. 2021 Feb 2
• 1 citations
  Ovarian mucinous neoplasms, intestinal type, in premenopausal patients, develop in abnormal ovaries.
  Elvio G. Silva, Anais Malpica, Andres A. Roma, Preetha Ramalingam, Grace Kim, Rania Bakkar, Sanam Loghavi, Stacey Kim, Alexandra Shaye-Brown, Mario L. Marques-Piubelli...> ;Human Pathology. 2021 Feb 1
• Join now to see all

Journal Articles

• KMT2D/MLL2 Inactivation Is Associated with Recurrence in Adult-Type Granulosa Cell Tumors of the Ovary  
  R Tyler Hillman, Karen H Lu, David M Gershenson, Nature

Lectures

• Scientific and Clinical Update in Gynecologic Oncology 
  Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 5/3/2013

Other

• Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis 
  Gershenson DM
  http://www.uptodate.com/contents/ovarian-germ-cell-neoplasms-pathology-clinical-manifestations-and-d
  UpToDate, Wolters Kluwer Health - 2012-08-08
• Overview of sex cord-stromal tumors of the ovary 
  Gershenson DM
  http://www.uptodate.com/contents/overview-of-sex-cord-stromal-tumors-of-the-ovary
  UpToDate, Wolters Kluwer Health - 2012-08-28
• Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors 
  Gershenson DM
  http://www.uptodate.com/contents/sex-cord-stromal-tumors-of-the-ovary-granulosa-stromal-cell-tumors
  UpToDate, Wolters Kluwer Health - 2012-12-17
• Sex cord-stromal tumors of the ovary: Sertoli-stromal cell tumors 
  Gershenson DM
  http://www.uptodate.com/contents/sex-cord-stromal-tumors-of-the-ovary-sertoli-stromal-cell-tumors
  UpToDate, Wolters Kluwer Health - 2013-01-30
• Sex cord-stromal tumors of the ovary: Tumors with granulosa and Sertoli-Leydig elements 
  Gershenson DM
  http://www.uptodate.com/contents/sex-cord-stromal-tumors-of-the-ovary-tumors-with-granulosa-and-sert
  UpToDate, Wolters Kluwer Health - 2013-03-29
• Join now to see all